Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines

NCT04157686 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT04157686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04157686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Long-term, Open-label Study to Evaluate the Safety of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines and Lateral Canthal Lines
Lead sponsor
Medy-Tox
Phase
Phase 3
Overall status
Completed
Start date
October 23, 2019
Completion date
February 16, 2023
Enrollment
957 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar lines, lateral canthal lines